ERCC6L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.917800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.754200E-01
Normal-vs-Stage2
3.448600E-01
Normal-vs-Stage3
8.392200E-01
Normal-vs-Stage4
4.669200E-01
Stage1-vs-Stage2
5.625600E-01
Stage1-vs-Stage3
7.473600E-01
Stage1-vs-Stage4
6.110800E-01
Stage2-vs-Stage3
3.870200E-01
Stage2-vs-Stage4
7.560000E-01
Stage3-vs-Stage4
4.489000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.930800E-01
Normal-vs-AfricanAmerican
5.546000E-01
Normal-vs-Asian
2.884600E-01
Caucasian-vs-AfricanAmerican
6.841800E-01
Caucasian-vs-Asian
6.098000E-01
AfricanAmerican-vs-Asian
7.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.143000E-01
Normal-vs-Female
3.590000E-01
Male-vs-Female
1.186220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.887200E-01
Normal-vs-Age(41-60Yrs)
3.745800E-01
Normal-vs-Age(61-80Yrs)
3.751200E-01
Normal-vs-Age(81-100Yrs)
3.012200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.316200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.506250E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.489960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.162410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.563000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.340800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.377000E-01
Normal-vs-Daily Drinker
3.844000E-01
Normal-vs-Weekly Drinker
4.793600E-01
Normal-vs-Occasional Drinker
3.313600E-01
Normal-vs-Social Drinker
3.629600E-01
Non Drinker-vs-Daily Drinker
7.882600E-01
Non Drinker-vs-Weekly Drinker
5.059400E-01
Non Drinker-vs-Occasional Drinker
7.156600E-01
Non Drinker-vs-Social Drinker
7.751000E-01
Daily Drinker-vs-Weekly Drinker
4.262600E-01
Daily Drinker-vs-Occasional Drinker
5.107000E-01
Daily Drinker-vs-Social Drinker
9.540400E-01
Weekly Drinker-vs-Occasional Drinker
6.417600E-01
Weekly Drinker-vs-Social Drinker
4.145600E-01
Occasional Drinker-vs-Social Drinker
5.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.563800E-01
Normal-vs-Grade 2
5.992200E-01
Normal-vs-Grade 3
6.195200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.843700E-03
Grade 1-vs-Grade 3
3.616900E-04
Grade 1-vs-Grade 4
5.563800E-01
Grade 2-vs-Grade 3
1.520010E-01
Grade 2-vs-Grade 4
5.992200E-01
Grade 3-vs-Grade 4
6.195200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.777600E-01
Normal-vs-NonDiabetic
3.791400E-01
Diabetic-vs-NonDiabetic
2.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.325000E-01
Normal-vs-NoPancreatitis
4.409400E-01
Pancreatitis-vs-NoPancreatitis
5.415000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.306200E-01
Normal-vs-N1
3.578600E-01
N0-vs-N1
2.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.116970E-01
Normal-vs-TP53-NonMutant
4.447800E-01
TP53-Mutant-vs-TP53-NonMutant
4.4350999999998E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
